We are live on ! Find out more
NVCR icon

NovoCure
NVCR

128 hedge funds and large institutions have $778M invested in NovoCure in 2017 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 43 increasing their positions, 28 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

352% more call options, than puts

Call options by funds: $20.2M | Put options by funds: $4.46M

240% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 10

54% more repeat investments, than reductions

Existing positions increased: 43 | Existing positions reduced: 28

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

23% more funds holding

Funds holding: 104 → 128 (+24)

4% more capital invested

Capital invested by funds: $746M → $778M (+$31.9M)

0.87% more ownership

Funds ownership: 42.2% → 43.07% (+0.87%)

Holders
128
Holders Change
+24
Holders Change %
+23.08%
% of All Funds
2.9%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
34
Increased
43
Reduced
28
Closed
10
Calls
$20.2M
Puts
$4.46M
Net Calls
+$15.7M
Net Calls Change
-$3.94M

Top Buyers

Rank Fund Capital Flow
1
FCM
Farallon Capital Management
California
+$22.4M
2
WRF
Waddell & Reed Financial
Kansas
+$17M
3
GPP
Great Point Partners
Connecticut
+$13.5M
4
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$11.6M
5
Allianz Asset Management
Allianz Asset Management
Germany
+$10.3M

Top Sellers

Rank Fund Capital Flow
1
Goldman Sachs
Goldman Sachs
New York
-$92.1M
2
PC
PointState Capital
New York
-$14.9M
3
AC
Ascend Capital
California
-$13M
4
LCM
Laurion Capital Management
New York
-$9.29M
5
JG
Jefferies Group
New York
-$6.45M
Name Holding Trade Value Shares
Change 		Change in
Stake
EWM
126
Edge Wealth Management
New York
$1K +$1.54K +80 New
PCG
127
Private Capital Group
Connecticut
$16 +$15.7K +813 New
PC
128
PointState Capital
New York
– -$14.9M -752,900 Closed
AC
129
Ascend Capital
California
– -$13M -654,152 Closed
JG
130
Jefferies Group
New York
– -$6.45M -325,000 Closed
MWNA
131
Marshall Wace North America
New York
– -$4.15M -207,591 Closed
RGI
132
River Global Investors
United Kingdom
– -$1.78M -89,451 Closed
DTL
133
Dynamic Technology Lab
Singapore
– -$691K -34,828 Closed
NFA
134
Nationwide Fund Advisors
Ohio
– -$637K -32,094 Closed
FRM
135
Fox Run Management
Connecticut
– -$461K -23,200 Closed
AP
136
AHL Partners
United Kingdom
– -$231K -11,639 Closed
FAM
137
Fred Alger Management
New York
– -$20K -1,000 Closed
MAM
138
Meeder Asset Management
Ohio
– +$58 +3 New
2 3 4 5
6

NVCR Hedge Fund Activity: Q4 2017 in Review

128 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in NovoCure (NVCR) for Q4 2017, worth a combined $778M — up 4.3% from $746M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new NVCR positions and 10 closed out — a net gain of 24 holders — while 43 added to existing stakes and 28 trimmed.

The largest buyer was Farallon Capital Management, opening a new position worth an estimated $22.4M. The largest seller was Goldman Sachs, cutting an estimated $92.1M.

  • 128 institutional investors held NovoCure (NVCR) as of Q4 2017, up from 104 in Q3 2017.
  • Funds reported $778M of NovoCure stock for Q4 2017, up 4.3% quarter-over-quarter.
  • 34 funds opened new NovoCure positions in Q4 2017 and 10 closed out, a net change of +24 holders.
  • The largest NovoCure buyer in Q4 2017 was Farallon Capital Management, an estimated $22.4M added.
  • The largest NovoCure seller in Q4 2017 was Goldman Sachs, an estimated $92.1M sold.

Based on aggregated 13F filings for Q4 2017.